BIOMAT Database Logo BIOMAT Database Logo

Treatment of oral verrucous carcinoma with carbon dioxide laser. 2007

Luciane H Azevedo, and Vivian C Galletta, and Carlos de Paula Eduardo, and Suzana O M de Sousa, and Dante A Migliari
Master's Professional Program on Lasers in Dentistry (IPEN), Clinician at the Special Laboratory of Lasers in Dentistry, School of Dentistry, University of São Paulo, São Paulo, Brazil.

UI MeSH Term Description Entries
D007972 Leukoplakia, Oral A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY). Keratosis, Oral,Leukokeratosis, Oral,Keratoses, Oral,Leukokeratoses, Oral,Leukoplakias, Oral,Oral Keratoses,Oral Keratosis,Oral Leukokeratoses,Oral Leukokeratosis,Oral Leukoplakia,Oral Leukoplakias
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014062 Tongue Neoplasms Tumors or cancer of the TONGUE. Cancer of Tongue,Tongue Cancer,Cancer of the Tongue,Neoplasms, Tongue,Cancer, Tongue,Cancers, Tongue,Neoplasm, Tongue,Tongue Cancers,Tongue Neoplasm
D014212 Tretinoin An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). Retinoic Acid,Vitamin A Acid,Retin-A,Tretinoin Potassium Salt,Tretinoin Sodium Salt,Tretinoin Zinc Salt,Vesanoid,all-trans-Retinoic Acid,beta-all-trans-Retinoic Acid,trans-Retinoic Acid,Acid, Retinoic,Acid, Vitamin A,Acid, all-trans-Retinoic,Acid, beta-all-trans-Retinoic,Acid, trans-Retinoic,Potassium Salt, Tretinoin,Retin A,Salt, Tretinoin Potassium,Salt, Tretinoin Sodium,Salt, Tretinoin Zinc,Sodium Salt, Tretinoin,Zinc Salt, Tretinoin,all trans Retinoic Acid,beta all trans Retinoic Acid,trans Retinoic Acid
D014945 Wound Healing Restoration of integrity to traumatized tissue. Healing, Wound,Healings, Wound,Wound Healings
D016609 Neoplasms, Second Primary Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause. Neoplasms, Metachronous,Neoplasms, Metachronous Second Primary,Neoplasms, Therapy-Related,Neoplasms, Treatment-Related,Second Malignancy,Second Neoplasm,Second Primary Neoplasms,Therapy-Associated Neoplasms,Therapy-Related Cancer,Treatment-Associated Neoplasms,Treatment-Related Cancer,Cancer, Second Primary,Metachronous Neoplasms,Metachronous Second Primary Neoplasms,Neoplasms, Therapy-Associated,Neoplasms, Treatment-Associated,Second Cancer,Second Primary Neoplasms, Metachronous,Therapy-Associated Cancer,Therapy-Related Neoplasms,Treatment-Associated Cancer,Treatment-Related Neoplasms,Cancer, Second,Cancer, Therapy-Associated,Cancer, Therapy-Related,Cancer, Treatment-Associated,Cancer, Treatment-Related,Cancers, Second,Cancers, Second Primary,Cancers, Therapy-Associated,Cancers, Therapy-Related,Cancers, Treatment-Associated,Cancers, Treatment-Related,Malignancies, Second,Malignancy, Second,Metachronous Neoplasm,Neoplasm, Metachronous,Neoplasm, Second,Neoplasm, Second Primary,Neoplasm, Therapy-Associated,Neoplasm, Therapy-Related,Neoplasm, Treatment-Associated,Neoplasm, Treatment-Related,Neoplasms, Second,Neoplasms, Therapy Associated,Neoplasms, Therapy Related,Neoplasms, Treatment Associated,Neoplasms, Treatment Related,Second Cancers,Second Malignancies,Second Neoplasms,Second Primary Cancer,Second Primary Cancers,Second Primary Neoplasm,Therapy Associated Cancer,Therapy Associated Neoplasms,Therapy Related Cancer,Therapy Related Neoplasms,Therapy-Associated Cancers,Therapy-Associated Neoplasm,Therapy-Related Cancers,Therapy-Related Neoplasm,Treatment Associated Cancer,Treatment Associated Neoplasms,Treatment Related Cancer,Treatment Related Neoplasms,Treatment-Associated Cancers,Treatment-Associated Neoplasm,Treatment-Related Cancers,Treatment-Related Neoplasm

Related Publications

Luciane H Azevedo, and Vivian C Galletta, and Carlos de Paula Eduardo, and Suzana O M de Sousa, and Dante A Migliari
Oral verrucous carcinoma treated with carbon dioxide laser.
August 2010, Journal of the European Academy of Dermatology and Venereology : JEADV,
Luciane H Azevedo, and Vivian C Galletta, and Carlos de Paula Eduardo, and Suzana O M de Sousa, and Dante A Migliari
Oral verrucous carcinoma treated with imiquimod 5% cream and carbon dioxide laser.
January 2011, European journal of dermatology : EJD,
Luciane H Azevedo, and Vivian C Galletta, and Carlos de Paula Eduardo, and Suzana O M de Sousa, and Dante A Migliari
Carbon dioxide laser cordectomy for verrucous carcinoma of vocal folds.
January 2010, The Journal of laryngology and otology,
Luciane H Azevedo, and Vivian C Galletta, and Carlos de Paula Eduardo, and Suzana O M de Sousa, and Dante A Migliari
Recalcitrant lip verrucous carcinoma successfully treated with acitretin after carbon dioxide laser ablation.
July 2018, JAAD case reports,
Luciane H Azevedo, and Vivian C Galletta, and Carlos de Paula Eduardo, and Suzana O M de Sousa, and Dante A Migliari
[Treatment of supraglottic carcinoma with carbon dioxide laser].
October 2008, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery,
Luciane H Azevedo, and Vivian C Galletta, and Carlos de Paula Eduardo, and Suzana O M de Sousa, and Dante A Migliari
Lip verrucous carcinoma in a pregnant woman successfully treated with carbon dioxide laser surgery.
October 2007, The British journal of dermatology,
Luciane H Azevedo, and Vivian C Galletta, and Carlos de Paula Eduardo, and Suzana O M de Sousa, and Dante A Migliari
Treatment of oral mucosal neuromas with carbon dioxide laser.
August 2019, Journal of the American Academy of Dermatology,
Luciane H Azevedo, and Vivian C Galletta, and Carlos de Paula Eduardo, and Suzana O M de Sousa, and Dante A Migliari
Successful carbon dioxide laser treatment for verrucous epidermal nevi on the nipple.
December 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
Luciane H Azevedo, and Vivian C Galletta, and Carlos de Paula Eduardo, and Suzana O M de Sousa, and Dante A Migliari
Carbon dioxide laser treatment of oral florid papillomatosis.
January 1984, The Journal of dermatologic surgery and oncology,
Luciane H Azevedo, and Vivian C Galletta, and Carlos de Paula Eduardo, and Suzana O M de Sousa, and Dante A Migliari
Oral verrucous carcinoma. Treatment with radiotherapy.
February 1988, Cancer,
Copied contents to your clipboard!